Gentian Diagnostics ASA (OSL:GENT)
Norway · Delayed Price · Currency is NOK 36.30
-1.40 (-3.71%)
Jun 4, 2026, 9:16 AM CET
Gentian Diagnostics ASA Market Cap
Gentian Diagnostics ASA has a market cap or net worth of 582.79 million as of June 3, 2026. Its market cap has decreased by -33.70% in one year.
Market Cap
582.79M
Enterprise Value
508.62M
Revenue
175.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
36.30
Market Cap Chart
Since December 14, 2016, Gentian Diagnostics ASA's market cap has increased from 289.62M to 582.79M, an increase of 101.23%. That is a compound annual growth rate of 7.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 582.79M | -33.00% |
| Dec 30, 2025 | 869.82M | 43.88% |
| Dec 30, 2024 | 604.56M | -5.54% |
| Dec 29, 2023 | 640.03M | 1.22% |
| Dec 30, 2022 | 632.32M | -43.06% |
| Dec 30, 2021 | 1.11B | 32.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.10B |
| Nordhealth AS | 2.06B |
| Circio Holding ASA | 2.03B |
| Photocure ASA | 1.61B |
| ArcticZymes Technologies ASA | 1.06B |
| Vistin Pharma ASA | 909.06M |
| Lytix Biopharma ASA | 761.31M |
| Omda AS | 738.28M |